| Does possessing specialized knowledge or skills alter the ethical landscape of medical decisions? In other words, should someone with the capacity to administer an experimental treatment be held to a different standard than those without such expertise? Let’s say an individual opts for a less effective or accessible treatment due to personal limitations or lack of knowledge: does this alter the ethical weight of their decision? This question becomes more complex when treatments have varying degrees of risk and benefit. If a treatment is simply an off-label, it often goes totally unnoticed unless it carries an unacceptable risk. Under that condition, what happens when the treatment holds significant promise, potentially offering a curative outcome? But it doesn’t yet have medical trials? Does the prospect of a cure override the ethical concerns about its risks? Where is that line? When faced with a life-threatening disease like recurring cancer, what is the individual’s responsibility to society in considering the ethics of self-treatment? Should she have accepted less effective therapy that had already lead to a failure condition for the good of the rest of us even though we are barely effected? How do the potential benefits to the individual—such as survival—contrast with the potential societal harm, if any, in terms of bypassing established protocols or ignoring sanctioned research? At what point does the line blur between personal medical autonomy and the ethical implications of self-administered treatments? I really do wonder about these questions. I mean, the only difference between the ‘ivermectin cures cancer’ et al crowd and this lady is her degree of knowledge, so how do we deal with this ethically? |